KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $2.0 million.

  • Pfizer's Exchange Rate Effect rose 10540.54% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year increase of 9880.95%. This contributed to the annual value of -$66.0 million for FY2024, which is 6500.0% down from last year.
  • Pfizer's Exchange Rate Effect amounted to $2.0 million in Q3 2025, which was up 10540.54% from $41.0 million recorded in Q2 2025.
  • In the past 5 years, Pfizer's Exchange Rate Effect ranged from a high of $41.0 million in Q2 2025 and a low of -$139.0 million during Q4 2022
  • Over the past 5 years, Pfizer's median Exchange Rate Effect value was -$7.0 million (recorded in 2025), while the average stood at -$21.3 million.
  • As far as peak fluctuations go, Pfizer's Exchange Rate Effect plummeted by 142000.0% in 2022, and later surged by 32777.78% in 2025.
  • Over the past 5 years, Pfizer's Exchange Rate Effect (Quarter) stood at -$32.0 million in 2021, then crashed by 334.38% to -$139.0 million in 2022, then skyrocketed by 99.28% to -$1.0 million in 2023, then plummeted by 3600.0% to -$37.0 million in 2024, then skyrocketed by 105.41% to $2.0 million in 2025.
  • Its Exchange Rate Effect was $2.0 million in Q3 2025, compared to $41.0 million in Q2 2025 and -$7.0 million in Q1 2025.